{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:42Z","timestamp":1792788342830,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QC169"],"award-info":[{"award-number":["ZR2022QC169"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32500156"],"award-info":[{"award-number":["32500156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Maternal and Child Health Association","award":["SFYZXJJ-2024017"],"award-info":[{"award-number":["SFYZXJJ-2024017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00775-4","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:02:00Z","timestamp":1763604120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fusobacterium nucleatum: a transboundary pathogen in host-microbiota networks"],"prefix":"10.1186","volume":"17","author":[{"given":"Xueyan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"1","key":"775_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2489070","volume":"17","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, Li X, Wang X, Deng B, He H, Xu M, et al. Fusobacterium nucleatum exacerbates colitis via STAT3 activation induced by Acetyl-CoA accumulation. Gut Microbes. 2025;17(1):2489070.","journal-title":"Gut Microbes"},{"key":"775_CR2","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.2147\/JIR.S470376","volume":"17","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li B, Bao L, Chen Y, Yang J, Xu F, et al. Fusobacterium nucleatum aggravates intestinal barrier impairment and colitis through IL-8 induced neutrophil chemotaxis by activating epithelial cells. J Inflamm Res. 2024;17:8407\u201320.","journal-title":"J Inflamm Res"},{"issue":"9","key":"775_CR3","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1093\/gbe\/evw199","volume":"8","author":"MY Ang","year":"2016","unstructured":"Ang MY, Dutta A, Wee WY, Dymock D, Paterson IC, Choo SW. Comparative genome analysis of Fusobacterium nucleatum. Genome Biol Evol. 2016;8(9):2928\u201338.","journal-title":"Genome Biol Evol"},{"issue":"1","key":"775_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30957-6","volume":"13","author":"D Bi","year":"2022","unstructured":"Bi D, Zhu Y, Gao Y, Li H, Zhu X, Wei R, et al. Profiling Fusobacterium infection at high taxonomic resolution reveals lineage-specific correlations in colorectal cancer. Nat Commun. 2022;13(1):3336.","journal-title":"Nat Commun"},{"issue":"10","key":"775_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00284-017-1296-9","volume":"74","author":"JK Kook","year":"2017","unstructured":"Kook JK, Park SN, Lim YK, Cho E, Jo E, Roh H, et al. Genome-based reclassification of Fusobacterium nucleatum subspecies at the species level. Curr Microbiol. 2017;74(10):1137\u201347.","journal-title":"Curr Microbiol"},{"issue":"4","key":"775_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.chom.2024.02.010","volume":"32","author":"M Krieger","year":"2024","unstructured":"Krieger M, AbdelRahman YM, Choi D, Palmer EA, Yoo A, McGuire S, et al. Stratification of Fusobacterium nucleatum by local health status in the oral cavity defines its subspecies disease association. Cell Host Microbe. 2024;32(4):479\u2013e4884.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"775_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.05184-22","volume":"11","author":"X Ma","year":"2023","unstructured":"Ma X, Sun T, Zhou J, Zhi M, Shen S, Wang Y, et al. Pangenomic study of Fusobacterium nucleatum reveals the distribution of pathogenic genes and functional clusters at the subspecies and strain levels. Microbiol Spectr. 2023;11(3):e05184\u201322.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"775_CR8","doi-asserted-by":"publisher","first-page":"e02991","DOI":"10.1128\/mbio.02991-21","volume":"13","author":"J Queen","year":"2022","unstructured":"Queen J, Domingue JC, White JR, Stevens C, Udayasuryan B, Nguyen TTD, et al. Comparative analysis of colon cancer-derived Fusobacterium nucleatum subspecies: inflammation and colon tumorigenesis in murine models. mBio. 2022;13(1):e02991\u201321.","journal-title":"mBio"},{"issue":"6","key":"775_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.anaerobe.2008.12.003","volume":"14","author":"J Strauss","year":"2008","unstructured":"Strauss J, White A, Ambrose C, McDonald J, Allen-Vercoe E. Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. Anaerobe. 2008;14(6):301\u20139.","journal-title":"Anaerobe"},{"issue":"7","key":"775_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/1940-6207.CAPR-16-0178","volume":"10","author":"X Ye","year":"2017","unstructured":"Ye X, Wang R, Bhattacharya R, Boulbes DR, Fan F, Xia L, et al. Fusobacterium nucleatum subspecies animalis influences proinflammatory cytokine expression and monocyte activation in human colorectal tumors. Cancer Prev Res. 2017;10(7):398\u2013409.","journal-title":"Cancer Prev Res"},{"key":"775_CR11","doi-asserted-by":"crossref","unstructured":"Kook JK, Park SN, Lim YK, Choi MH, Cho E, Kong SW et al. Fusobacterium nucleatum subsp fusiforme Gharbia and Shah 1992 is a later synonym of Fusobacterium nucleatum subsp vincentii Dzink 1990. Curr Microbiol. 2013;66(4):414\u20137.","DOI":"10.1007\/s00284-012-0289-y"},{"issue":"12","key":"775_CR12","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1128\/IAI.67.12.6439-6444.1999","volume":"67","author":"H Darenfed","year":"1999","unstructured":"Darenfed H, Grenier D, Mayrand D. Acquisition of plasmin activity by Fusobacterium nucleatum subsp. nucleatum and potential contribution to tissue destruction during periodontitis. Infect Immun. 1999;67(12):6439\u201344.","journal-title":"Infect Immun"},{"issue":"2","key":"775_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1472-765X.1990.tb00276.x","volume":"10","author":"SE Gharbia","year":"1990","unstructured":"Gharbia SE, Shah HN. Heterogeneity within Fusobacterium nucleatum, proposal of four subspecies. Lett Appl Microbiol. 1990;10(2):105\u20138.","journal-title":"Lett Appl Microbiol"},{"issue":"4","key":"775_CR14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1053\/j.gastro.2020.11.034","volume":"160","author":"MA Engevik","year":"2021","unstructured":"Engevik MA, Danhof HA, Auchtung J, Endres BT, Ruan W, Bass\u00e8res E, et al. Fusobacteriumnucleatum adheres to clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus. Gastroenterology. 2021;160(4):1301\u2013e13148.","journal-title":"Gastroenterology"},{"issue":"1","key":"775_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3892\/ijmm.2020.4780","volume":"47","author":"C Duan","year":"2021","unstructured":"Duan C, Tang X, Wang W, Qian W, Fu X, Deng X, et al. Lactobacillus rhamnosus attenuates intestinal inflammation induced by Fusobacterium nucleatum infection by restoring the autophagic flux. Int J Mol Med. 2021;47(1):125\u201336.","journal-title":"Int J Mol Med"},{"issue":"2","key":"775_CR16","first-page":"e01573","volume":"16","author":"GW Lawrence","year":"2024","unstructured":"Lawrence GW, Garcia-Gutierrez E, O\u2019Mahony AK, Walsh CJ, O\u2019Connor PM, Begley M, et al. A gut-derived Streptococcus salivarius produces the novel Nisin variant designated Nisin G and inhibits Fusobacterium nucleatum in a model of the human distal colon Microbiome. mBio. 2024;16(2):e01573\u201324.","journal-title":"mBio"},{"issue":"1","key":"775_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45572-w","volume":"15","author":"H Zhu","year":"2024","unstructured":"Zhu H, Li M, Bi D, Yang H, Gao Y, Song F, et al. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15. Nat Commun. 2024;15(1):1688.","journal-title":"Nat Commun"},{"issue":"3","key":"775_CR18","doi-asserted-by":"publisher","first-page":"e0223524","DOI":"10.1128\/spectrum.02235-24","volume":"13","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Yang M, Fang H, Niu Y, Lu J, Ma Y, et al. Interspecies interactions mediated by arginine metabolism enhance the stress tolerance of Fusobacterium nucleatum against bifidobacterium animalis. Microbiol Spectr. 2025;13(3):e0223524.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"775_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13010093","volume":"13","author":"B Wang","year":"2024","unstructured":"Wang B, Deng J, Donati V, Merali N, Frampton AE, Giovannetti E, et al. The roles and interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in oral and gastrointestinal carcinogenesis: a narrative review. Pathogens. 2024;13(1):93.","journal-title":"Pathogens"},{"issue":"5","key":"775_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/omi.12177","volume":"32","author":"L Guo","year":"2017","unstructured":"Guo L, Shokeen B, He X, Shi W, Lux R. Streptococcus mutans spap binds to RadD of Fusobacterium nucleatum ssp. polymorphum. Mol Oral Microbiol. 2017;32(5):355\u201364.","journal-title":"Mol Oral Microbiol"},{"issue":"1","key":"775_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01865-z","volume":"10","author":"X Chen","year":"2024","unstructured":"Chen X, Ma Z, Yi Z, Wu E, Shang Z, Tuo B, et al. The effects of metabolism on the immune microenvironment in colorectal cancer. Cell Death Discov. 2024;10(1):118.","journal-title":"Cell Death Discov"},{"issue":"11","key":"775_CR22","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1136\/gutjnl-2020-322780","volume":"70","author":"J Hong","year":"2021","unstructured":"Hong J, Guo F, Lu SY, Shen C, Ma D, Zhang X, et al. F. nucleatum targets LncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut. 2021;70(11):2123\u201337.","journal-title":"Gut"},{"issue":"3","key":"775_CR23","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.230014","volume":"13","author":"LM Ney","year":"2023","unstructured":"Ney LM, Wipplinger M, Grossmann M, Engert N, Wegner VD, Mosig AS. Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections. Open Biol. 2023;13(3):230014.","journal-title":"Open Biol"},{"key":"775_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1353787","volume":"15","author":"A Nicolini","year":"2024","unstructured":"Nicolini A, Ferrari P. Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy. Front Immunol. 2024;15:1353787.","journal-title":"Front Immunol"},{"issue":"1","key":"775_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/gut.52.1.79","volume":"52","author":"T Ohkusa","year":"2003","unstructured":"Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut. 2003;52(1):79\u201383.","journal-title":"Gut"},{"issue":"2","key":"775_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166984","volume":"1870","author":"H Chen","year":"2024","unstructured":"Chen H, Qian Y, Jiang C, Tang L, Yu J, Zhang L, et al. Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2\/GPX4 signal pathway and improving intestinal barrier. Biochimica et Biophysica Acta (BBA). 2024;1870(2):166984.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"775_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbrc.2012.02.051","volume":"419","author":"M Chattopadhyay","year":"2012","unstructured":"Chattopadhyay M, Kodela R, Olson KR, Kashfi K. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. Biochem Biophys Res Commun. 2012;419(3):523\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"775_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bcp.2011.12.018","volume":"83","author":"M Chattopadhyay","year":"2012","unstructured":"Chattopadhyay M, Kodela R, Nath N, Dastagirzada YM, Vel\u00e1zquez-Mart\u00ednez CA, Boring D, et al. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochem Pharmacol. 2012;83(6):715\u201322.","journal-title":"Biochem Pharmacol"},{"key":"775_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.mie.2014.11.034","volume":"555","author":"B Gemici","year":"2015","unstructured":"Gemici B, Wallace JL. Anti-inflammatory and cytoprotective properties of hydrogen sulfide. Methods Enzymol. 2015;555:169\u201393.","journal-title":"Methods Enzymol"},{"issue":"5","key":"775_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/ars.2013.5308","volume":"20","author":"K Kashfi","year":"2014","unstructured":"Kashfi K. Anti-cancer activity of new designer hydrogen sulfide-donating hybrids. Antioxid Redox Signal. 2014;20(5):831\u201346.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"775_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1541-7786.MCR-06-0439","volume":"5","author":"MS Attene-Ramos","year":"2007","unstructured":"Attene-Ramos MS, Wagner ED, Gaskins HR, Plewa MJ. Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res. 2007;5(5):455\u20139.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"775_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/1541-7786.MCR-05-0126","volume":"4","author":"MS Attene-Ramos","year":"2006","unstructured":"Attene-Ramos MS, Wagner ED, Plewa MJ, Gaskins HR. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res. 2006;4(1):9\u201314.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"775_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/ecp.10.131","volume":"4","author":"G Yang","year":"2011","unstructured":"Yang G. Hydrogen sulfide in cell survival: a double-edged sword. Expert Rev Clin Pharmacol. 2011;4(1):33\u201347.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"775_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1101\/gr.126516.111","volume":"22","author":"M Castellarin","year":"2012","unstructured":"Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299\u2013306.","journal-title":"Genome Res"},{"issue":"22","key":"775_CR35","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1158\/1078-0432.CCR-16-1786","volume":"22","author":"K Yamamura","year":"2016","unstructured":"Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, et al. Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 2016;22(22):5574\u201381.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"775_CR36","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.18632\/oncotarget.3109","volume":"6","author":"K Mitsuhashi","year":"2015","unstructured":"Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015;6(9):7209\u201320.","journal-title":"Oncotarget"},{"key":"775_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11:3259.","journal-title":"Nat Commun"},{"issue":"6","key":"775_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110157","volume":"27","author":"J Galaski","year":"2024","unstructured":"Galaski J, Rishiq A, Liu M, Bsoul R, Bergson A, Lux R, et al. Fusobacterium nucleatum subsp. nucleatum RadD binds Siglec-7 and inhibits NK cell-mediated cancer cell killing. iScience. 2024;27(6):110157.","journal-title":"iScience"},{"issue":"6","key":"775_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1581531","volume":"8","author":"C Gur","year":"2019","unstructured":"Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, et al. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Oncoimmunology. 2019;8(6):e1581531.","journal-title":"Oncoimmunology"},{"issue":"1","key":"775_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2018.1565043","volume":"11","author":"ML Brewer","year":"2019","unstructured":"Brewer ML, Dymock D, Brady RL, Singer BB, Virji M, Hill DJ. Fusobacterium spp. target human CEACAM1 via the trimeric autotransporter adhesin CbpF. J Oral Microbiol. 2019;11(1):1565043.","journal-title":"J Oral Microbiol"},{"issue":"2","key":"775_CR41","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344\u201355.","journal-title":"Immunity"},{"issue":"1","key":"775_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2399217","volume":"15","author":"D Li","year":"2024","unstructured":"Li D, Li Z, Wang L, Zhang Y, Ning S. Oral inoculation of Fusobacterium nucleatum exacerbates ulcerative colitis via the secretion of virulence adhesin FadA. Virulence. 2024;15(1):2399217.","journal-title":"Virulence"},{"issue":"7","key":"775_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152891","volume":"22","author":"Q Meng","year":"2021","unstructured":"Meng Q, Gao Q, Mehrazarin S, Tangwanichgapong K, Wang Y, Huang Y, et al. Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity. EMBO Rep. 2021;22(7):e52891.","journal-title":"EMBO Rep"},{"key":"775_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01677-w","volume":"39","author":"P Guo","year":"2020","unstructured":"Guo P, Tian Z, Kong X, Yang L, Shan X, Dong B, et al. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. J Exp Clin Cancer Res. 2020;39(1):202.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"775_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195\u2013206.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"775_CR46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.chom.2023.03.018","volume":"31","author":"M Hong","year":"2023","unstructured":"Hong M, Li Z, Liu H, Zheng S, Zhang F, Zhu J, et al. Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesicles. Cell Host Microbe. 2023;31(5):798\u2013e8107.","journal-title":"Cell Host Microbe"},{"key":"775_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583644","volume":"11","author":"C Martin-Gallausiaux","year":"2020","unstructured":"Martin-Gallausiaux C, Malabirade A, Habier J, Wilmes P. Fusobacterium nucleatum extracellular vesicles modulate gut epithelial cell innate immunity via FomA and TLR2. Front Immunol. 2020;11:583644.","journal-title":"Front Immunol"},{"issue":"1","key":"775_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011096","volume":"19","author":"Y Wu","year":"2023","unstructured":"Wu Y, Guo S, Chen F, Li Y, Huang Y, Liu W, et al. Fn-dps, a novel virulence factor of Fusobacterium nucleatum, disrupts erythrocytes and promotes metastasis in colorectal cancer. PLoS Pathog. 2023;19(1):e1011096.","journal-title":"PLoS Pathog"},{"issue":"4","key":"775_CR49","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.chom.2024.03.009","volume":"32","author":"BG C","year":"2024","unstructured":"C BG, Zhou P, Wu C. Fusobacterium nucleatum subsp. Animalis comes to the spotlight in oral diseases. Cell Host Microbe. 2024;32(4):443\u20134.","journal-title":"Cell Host Microbe"},{"key":"775_CR50","doi-asserted-by":"publisher","first-page":"744184","DOI":"10.3389\/fimmu.2021.744184","volume":"12","author":"D Lamprinaki","year":"2021","unstructured":"Lamprinaki D, Garcia-Vello P, Marchetti R, Hellmich C, McCord KA, Bowles KM, et al. Siglec-7 mediates Immunomodulation by colorectal cancer-associated Fusobacterium nucleatum ssp. Animalis. Front Immunol. 2021;12:744184.","journal-title":"Front Immunol"},{"issue":"8007","key":"775_CR51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","volume":"628","author":"M Zepeda-Rivera","year":"2024","unstructured":"Zepeda-Rivera M, Minot SS, Bouzek H, Wu H, Blanco-M\u00edguez A, Manghi P, et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature. 2024;628(8007):424\u201332.","journal-title":"Nature"},{"key":"775_CR52","doi-asserted-by":"crossref","unstructured":"Engevik MA, Danhof HA, Ruan W, Engevik AC, Chang-Graham AL, Engevik KA, et al. Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. mBio. 2021; 12(2):e02706-20.","DOI":"10.1128\/mBio.02706-20"},{"key":"775_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-017-0967-9","volume":"17","author":"A Basic","year":"2017","unstructured":"Basic A, Blomqvist M, Dahl\u00e9n G, Svens\u00e4ter G. The proteins of Fusobacterium spp. involved in hydrogen sulfide production from l-cysteine. BMC Microbiol. 2017;17(1):61.","journal-title":"BMC Microbiol"},{"issue":"12","key":"775_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11122957","volume":"11","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kamiya T, Yano M, Huyen VT, Oishi M, Nishio M, et al. Oral microbial profile analysis in patients with oral and pharyngeal cancer reveals that tumoral Fusobacterium nucleatum promotes oral cancer progression by activating YAP. Microorganisms. 2023;11(12):2957.","journal-title":"Microorganisms"},{"issue":"2","key":"775_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.imj.2024.100109","volume":"3","author":"Z Ma","year":"2024","unstructured":"Ma Z, Liu H, Liu M, Wang Y, Li C, Xu Y. Metagenomic next-generation sequencing identified a brain abscess caused by mixed oral anaerobe infection: a case report. Infect Med. 2024;3(2):100109.","journal-title":"Infect Med"},{"key":"775_CR56","first-page":"7241312","volume":"2019","author":"KQ de Andrade","year":"2019","unstructured":"de Andrade KQ, Almeida-da-Silva CLC, Coutinho-Silva R. Immunological pathways triggered by Porphyromonas gingivalis and Fusobacterium nucleatum. Therapeutic possibilities? Mediators Inflamm. 2019;2019:7241312.","journal-title":"Therapeutic possibilities? Mediators Inflamm"},{"issue":"1","key":"775_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jre.12185","volume":"50","author":"YB Shaik-Dasthagirisaheb","year":"2015","unstructured":"Shaik-Dasthagirisaheb YB, Huang N, Weinberg EO, Shen SS, Genco CA, Gibson FC. Aging and contribution of MyD88 and TRIF in expression of TLR pathway associated genes to Porphyromonas gingivalis. J Periodontal Res. 2015;50(1):89\u2013102.","journal-title":"J Periodontal Res"},{"issue":"1","key":"775_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/cre2.70098","volume":"11","author":"S Virkkunen","year":"2025","unstructured":"Virkkunen S, Kaarela T, Laine M, Suominen A, Hagstr\u00f6m J, Sorsa T, et al. Radicular cysts and periapical granulomas: data documentation for 696 cases and findings on fibrosis, and Porphyromonas gingivalis and Fusobacterium nucleatum in these lesions. Clin Exp Dent Res. 2025;11(1):e70098.","journal-title":"Clin Exp Dent Res"},{"issue":"2","key":"775_CR59","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12328-021-01376-9","volume":"14","author":"K Inoue","year":"2021","unstructured":"Inoue K, Watanabe Y, Nagata H, Kojima M. Pyogenic liver abscess caused by Fusobacterium nucleatum with an inflammatory scar in the abdominal cavity. Clin J Gastroenterol. 2021;14(2):617\u201320.","journal-title":"Clin J Gastroenterol"},{"key":"775_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1090-8","volume":"4","author":"SJS Nagpal","year":"2015","unstructured":"Nagpal SJS, Mukhija D, Patel P. Fusobacterium nucleatum: a rare cause of pyogenic liver abscess. Springerplus. 2015;4:283.","journal-title":"Springerplus"},{"issue":"10","key":"775_CR61","volume":"7","author":"N Swaminathan","year":"2020","unstructured":"Swaminathan N, Aguilar F. Cryptogenic pyogenic liver abscess due to Fusobacterium nucleatum in an immunocompetent patient. Eur J Case Rep Intern Med. 2020;7(10):001741.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"3","key":"775_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030368","volume":"17","author":"L Galasso","year":"2025","unstructured":"Galasso L, Termite F, Mignini I, Esposto G, Borriello R, Vitale F, et al. Unraveling the role of Fusobacterium nucleatum in colorectal cancer: molecular mechanisms and pathogenic insights. Cancers (Basel). 2025;17(3):368.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"775_CR63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","volume":"17","author":"CA Brennan","year":"2019","unstructured":"Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019;17(3):156\u201366.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"775_CR64","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2022.2145729","volume":"15","author":"Z Fan","year":"2022","unstructured":"Fan Z, Tang P, Li C, Yang Q, Xu Y, Su C, et al. Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms. J Oral Microbiol. 2022;15(1):2145729.","journal-title":"J Oral Microbiol"},{"issue":"10","key":"775_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105083","volume":"25","author":"L Ciani","year":"2024","unstructured":"Ciani L, Libonati A, Dri M, Pomella S, Campanella V, Barillari G. About a possible impact of endodontic infections by Fusobacterium nucleatum or Porphyromonas gingivalis on oral carcinogenesis: a literature overview. Int J Mol Sci. 2024;25(10):5083.","journal-title":"Int J Mol Sci"},{"key":"775_CR66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jare.2023.08.014","volume":"61","author":"S Guo","year":"2023","unstructured":"Guo S, Chen F, Li L, Dou S, Li Q, Huang Y, et al. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma. J Adv Res. 2023;61:165\u201378.","journal-title":"J Adv Res"},{"issue":"10","key":"775_CR67","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, et al. Intratumoral Fusobacterium nucleatum ecruits tumor-associated neutrophils to promote gastric cancer progression and immune evasion. Cancer Res. 2025;85(10):1819\u201341.","journal-title":"Cancer Res"},{"issue":"3","key":"775_CR68","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/15513815.2022.2131487","volume":"42","author":"MP Bonasoni","year":"2023","unstructured":"Bonasoni MP, Comitini G, Pati M, Bardaro M, Russello G, Carretto E, et al. Fulminant sepsis and perinatal death at 23 weeks due to Fusobacterium nucleatum. Fetal Pediatr Pathol. 2023;42(3):456\u201363.","journal-title":"Fetal Pediatr Pathol"},{"key":"775_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.815318","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Huang Z, Tang Z, Huang Y, Huang M, Liu H, et al. More than just a periodontal pathogen -the research progress on Fusobacterium nucleatum. Front Cell Infect Microbiol. 2022;12:815318.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2 Pt 2","key":"775_CR70","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/AOG.0b013e3181cb9955","volume":"115","author":"YW Han","year":"2010","unstructured":"Han YW, Fardini Y, Chen C, Iacampo KG, Peraino VA, Shamonki JM, et al. Term stillbirth caused by oral Fusobacterium nucleatum. Obstet Gynecol. 2010;115(2 Pt 2):442\u20135.","journal-title":"Obstet Gynecol"},{"key":"775_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.798685","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Liu L, Wu P, Zhao L, Wu Y. Fusobacterium nucleatum accelerates atherosclerosis via macrophage-driven aberrant proinflammatory response and lipid metabolism. Front Microbiol. 2022;13:798685.","journal-title":"Front Microbiol"},{"issue":"2","key":"775_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jiac.2016.09.013","volume":"23","author":"K Nagaoka","year":"2017","unstructured":"Nagaoka K, Yanagihara K, Harada Y, Yamada K, Migiyama Y, Morinaga Y, et al. Quantitative detection of periodontopathic bacteria in lower respiratory tract specimens by real-time PCR. J Infect Chemother. 2017;23(2):69\u201373.","journal-title":"J Infect Chemother"},{"issue":"9","key":"775_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12091110","volume":"12","author":"T Shi","year":"2023","unstructured":"Shi T, Wang J, Dong J, Hu P, Guo Q. Periodontopathogens Porphyromonas gingivalis and Fusobacterium nucleatum and their roles in the progression of respiratory diseases. Pathogens. 2023;12(9):1110.","journal-title":"Pathogens"},{"issue":"12","key":"775_CR74","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/cid\/ciab900","volume":"73","author":"Z Shen","year":"2021","unstructured":"Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Corrigendum to: genomic diversity of severe acute respiratory syndrome\u2013coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis. 2021;73(12):2374.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"775_CR75","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-121918","volume":"36","author":"S Poole","year":"2013","unstructured":"Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer\u2019s disease brain tissue. J Alzheimers Dis. 2013;36(4):665\u201377.","journal-title":"J Alzheimers Dis"},{"key":"775_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.884543","volume":"16","author":"C Yan","year":"2022","unstructured":"Yan C, Diao Q, Zhao Y, Zhang C, He X, Huang R, et al. Fusobacterium nucleatum infection-induced neurodegeneration and abnormal gut microbiota composition in Alzheimer\u2019s disease-like rats. Front Neurosci. 2022;16:884543.","journal-title":"Front Neurosci"},{"issue":"12","key":"775_CR77","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1021\/acsnano.3c12687","volume":"18","author":"S Geng","year":"2024","unstructured":"Geng S, Guo P, Li X, Shi Y, Wang J, Cao M, et al. Biomimetic nanovehicle-enabled targeted depletion of intratumoral Fusobacterium nucleatum synergizes with PD-L1 blockade against breast cancer. ACS Nano. 2024;18(12):8971\u201387.","journal-title":"ACS Nano"},{"issue":"1","key":"775_CR78","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1987780","volume":"13","author":"CA Brennan","year":"2021","unstructured":"Brennan CA, Clay SL, Lavoie SL, Bae S, Lang JK, Fonseca-Pereira D, et al. Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression. Gut Microbes. 2021;13(1):1987780.","journal-title":"Gut Microbes"},{"issue":"1","key":"775_CR79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/ibd\/izac177","volume":"29","author":"S Wei","year":"2023","unstructured":"Wei S, Zhang J, Wu X, Chen M, Huang H, Zeng S, et al. Fusobacterium nucleatum extracellular vesicles promote experimental colitis by modulating autophagy via the miR-574-5p\/CARD3 axis. Inflamm Bowel Dis. 2023;29(1):9\u201326.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"775_CR80","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","volume":"31","author":"SS Jiang","year":"2023","unstructured":"Jiang SS, Xie YL, Xiao XY, Kang ZR, Lin XL, Zhang L, et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe. 2023;31(5):781\u2013e7979.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"775_CR81","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2442037","volume":"17","author":"F Chen","year":"2025","unstructured":"Chen F, Guo S, Li Y, Lu Y, Liu L, Chen S, et al. Fusobacterium nucleatum-driven CX3CR1\u2009+\u2009PD-L1\u2009+\u2009phagocytes route to tumor tissues and reshape tumor microenvironment. Gut Microbes. 2025;17(1):2442037.","journal-title":"Gut Microbes"},{"key":"775_CR82","doi-asserted-by":"crossref","unstructured":"Gao Y. Fusobacterium nucleatum enhances the efficacy of PD-L1 Blockade in colorectal cancer. Signal Transduct Target Ther. 2021;6(1) :398.","DOI":"10.1038\/s41392-021-00795-x"},{"issue":"4","key":"775_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70070","volume":"14","author":"W Li","year":"2025","unstructured":"Li W, Zhang Z, Wu R, Mao M, Ji Y, Wang X, et al. Fusobacterium nucleatum-derived outer membrane vesicles promote immunotherapy resistance via changes in tryptophan metabolism in tumour\u2010associated macrophages. J Extracell Vesicles. 2025;14(4):e70070.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"775_CR84","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548\u2013e56316.","journal-title":"Cell"},{"issue":"1","key":"775_CR85","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/prd.12426","volume":"89","author":"T Alon-Maimon","year":"2022","unstructured":"Alon-Maimon T, Mandelboim O, Bachrach G. Fusobacterium nucleatum and cancer. Periodontol 2000. 2022;89(1):166\u201380.","journal-title":"Periodontol 2000"},{"issue":"1","key":"775_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2306676","volume":"25","author":"C Ye","year":"2024","unstructured":"Ye C, Liu X, Liu Z, Pan C, Zhang X, Zhao Z, et al. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance. Cancer Biol Ther. 2024;25(1):2306676.","journal-title":"Cancer Biol Ther"},{"key":"775_CR87","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.actbio.2025.02.013","volume":"195","author":"X Li","year":"2025","unstructured":"Li X. Multifunctional nanodrug for simultaneously combating chemoresistance and immunosuppression in Fusobacterium nucleatum-associated colorectal cancer. Acta Biomater. 2025;195:406\u201326.","journal-title":"Acta Biomater"},{"key":"775_CR88","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231176427","volume":"16","author":"LZ Shu","year":"2023","unstructured":"Shu LZ, Ding YD, Xue QM, Cai W, Deng H. Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier. Ther Adv Gastroenterol. 2023;16:17562848231176427.","journal-title":"Ther Adv Gastroenterol"},{"issue":"3","key":"775_CR89","doi-asserted-by":"publisher","first-page":"G171","DOI":"10.1152\/ajpgi.00048.2015","volume":"312","author":"JM Wells","year":"2017","unstructured":"Wells JM, Brummer RJ, Derrien M, MacDonald TT, Troost F, Cani PD, et al. Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol. 2017;312(3):G171\u201393.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"775_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103717","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, He C, Xia Y, Ocansey DKW, Mao F. Intestinal mucus barrier: a potential therapeutic target for IBD. Autoimmun Rev. 2025;24(2):103717.","journal-title":"Autoimmun Rev"},{"key":"775_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mib.2020.06.007","volume":"56","author":"AG Solis","year":"2020","unstructured":"Solis AG, Klapholz M, Zhao J, Levy M. The bidirectional nature of microbiome-epithelial cell interactions. Curr Opin Microbiol. 2020;56:45\u201351.","journal-title":"Curr Opin Microbiol"},{"key":"775_CR92","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.2147\/JIR.S474368","volume":"17","author":"H Luo","year":"2024","unstructured":"Luo H, Guo M, Li M, Zhao Y, Shen J, Du F, et al. Protective effect of Rosavin against intestinal epithelial injury in colitis mice and intestinal organoids. J Inflamm Res. 2024;17:6023\u201338.","journal-title":"J Inflamm Res"},{"issue":"7","key":"775_CR93","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1128\/IAI.05118-11","volume":"79","author":"P Dharmani","year":"2011","unstructured":"Dharmani P, Strauss J, Ambrose C, Allen-Vercoe E, Chadee K. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha. Infect Immun. 2011;79(7):2597\u2013607.","journal-title":"Infect Immun"},{"issue":"7","key":"775_CR94","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1021\/acs.jafc.3c08050","volume":"72","author":"X Zeng","year":"2024","unstructured":"Zeng X, Li J, Wang X, Liu L, Shen S, Li N, et al. Regulation of gut microbiota and microbial metabolome of kefir supernatant against Fusobacterium nucleatum and DSS-coinduced colitis. J Agric Food Chem. 2024;72(7):3536\u201348.","journal-title":"J Agric Food Chem"},{"issue":"7","key":"775_CR95","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/1751-2980.12909","volume":"21","author":"H Liu","year":"2020","unstructured":"Liu H, Hong XL, Sun TT, Huang XW, Wang JL, Xiong H. Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation. J Dig Dis. 2020;21(7):385\u201398.","journal-title":"J Dig Dis"},{"key":"775_CR96","doi-asserted-by":"publisher","unstructured":"Cao P, Chen Y, Guo X, Chen Y, Su W, Zhan N et al. Fusobacterium nucleatum activates endoplasmic reticulum stress to promote crohn\u2019s disease development via the upregulation of CARD3 expression. Front Pharmacol. 2021; 11:106. https:\/\/doi.org\/10.3389\/fphar.2020.00106","DOI":"10.3389\/fphar.2020.00106"},{"issue":"1","key":"775_CR97","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1902718","volume":"13","author":"L Liu","year":"2021","unstructured":"Liu L, Liang L, Yang C, Zhou Y, Chen Y. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes. 2021;13(1):1-20 .","journal-title":"Gut Microbes"},{"key":"775_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.594806","volume":"10","author":"W Su","year":"2020","unstructured":"Su W, Chen Y, Cao P, Chen Y, Guo Y, Wang S, et al. Fusobacterium nucleatum promotes the development of ulcerative colitis by inducing the autophagic cell death of intestinal epithelial. Front Cell Infect Microbiol. 2020;10:594806.","journal-title":"Front Cell Infect Microbiol"},{"key":"775_CR99","doi-asserted-by":"crossref","unstructured":"Jia Yping, Wang K, Zhang Z, jun, Tong Y nan, Han D, Hu C et al. yu,. TLR2\/TLR4 activation induces Tregs and suppresses intestinal inflammation caused by Fusobacterium nucleatum in vivo. Chamaillard M, editor. PLOS ONE. 2017;12(10):e0186179.","DOI":"10.1371\/journal.pone.0186179"},{"issue":"7","key":"775_CR100","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.archoralbio.2011.01.011","volume":"56","author":"CB Huang","year":"2011","unstructured":"Huang CB, Altimova Y, Myers TM, Ebersole JL. Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms. Arch Oral Biol. 2011;56(7):650\u20134.","journal-title":"Arch Oral Biol"},{"key":"775_CR101","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2023.09.028","volume":"363","author":"L Chen","year":"2023","unstructured":"Chen L, Zhao R, Kang Z, Cao Z, Liu N, Shen J, et al. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. J Control Release. 2023;363:43\u201356.","journal-title":"J Control Release"},{"issue":"8","key":"775_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13348","volume":"23","author":"A Dahlstrand Rudin","year":"2021","unstructured":"Dahlstrand Rudin A, Khamzeh A, Venkatakrishnan V, Basic A, Christenson K, Bylund J. Short chain fatty acids released by Fusobacterium nucleatum are neutrophil chemoattractants acting via free fatty acid receptor 2 (FFAR2). Cell Microbiol. 2021;23(8):e13348.","journal-title":"Cell Microbiol"},{"issue":"14","key":"775_CR103","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3748\/wjg.v30.i14.2018","volume":"30","author":"QL Wu","year":"2024","unstructured":"Wu QL, Fang XT, Wan XX, Ding QY, Zhang YJ, Ji L, et al. Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer. World J Gastroenterol. 2024;30(14):2018\u201337.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"775_CR104","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang X, Fang Y, Liang W, Wong CC, Qin H, Gao Y, et al. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell. 2024;42(10):1729\u2013e17468.","journal-title":"Cancer Cell"},{"key":"775_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111495","volume":"414","author":"Q Song","year":"2025","unstructured":"Song Q, Jin Z, Zhang H, Hong K, Zhu B, Yin H, et al. Fusobacterium nucleatum-derived 3-indolepropionic acid promotes colorectal cancer progression via Aryl hydrocarbon receptor activation in macrophages. Chem Biol Interact. 2025;414:111495.","journal-title":"Chem Biol Interact"},{"key":"775_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2021.111586","volume":"224","author":"K Stokowa-So\u0142tys","year":"2021","unstructured":"Stokowa-So\u0142tys K, Wojtkowiak K, Jagie\u0142\u0142o K. Fusobacterium nucleatum \u2013 friend or foe? J Inorg Biochem. 2021;224:111586.","journal-title":"J Inorg Biochem"},{"key":"775_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00417-0","volume":"9","author":"B Song","year":"2023","unstructured":"Song B, Xian W, Sun Y, Gou L, Guo Q, Zhou X, et al. Akkermansia muciniphila inhibited the periodontitis caused by Fusobacterium nucleatum. NPJ Biofilms Microbiomes. 2023;9:49.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"8","key":"775_CR108","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa044","volume":"78","author":"TA Santos","year":"2020","unstructured":"Santos TA, Scorzoni L, Correia R, Junqueira JC, Anbinder AL. Interaction between Lactobacillus reuteri and periodontopathogenic bacteria using in vitro and in vivo (G. mellonella) approaches. Pathog Dis. 2020;78(8):ftaa044.","journal-title":"Pathog Dis"},{"key":"775_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80921-x","volume":"11","author":"KM Yang","year":"2021","unstructured":"Yang KM, Kim JS, Kim HS, Kim YY, Oh JK, Jung HW, et al. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria. Sci Rep. 2021;11:1631.","journal-title":"Sci Rep"},{"issue":"1","key":"775_CR110","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2022.2149448","volume":"15","author":"D Xiang","year":"2022","unstructured":"Xiang D, Dong PT, Cen L, Bor B, Lux R, Shi W, et al. Antagonistic interaction between two key endodontic pathogens Enterococcus faecalis and Fusobacterium nucleatum. J Oral Microbiol. 2022;15(1):2149448.","journal-title":"J Oral Microbiol"},{"key":"775_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.879423","volume":"12","author":"R Yang","year":"2022","unstructured":"Yang R, Liu T, Pang C, Cai Y, Lin Z, Guo L, et al. The regulatory effect of coaggregation between Fusobacterium nucleatum and Streptococcus gordonii on the synergistic virulence to human gingival epithelial cells. Front Cell Infect Microbiol. 2022;12:879423.","journal-title":"Front Cell Infect Microbiol"},{"key":"775_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2019.102100","volume":"62","author":"A Horiuchi","year":"2020","unstructured":"Horiuchi A, Kokubu E, Warita T, Ishihara K. Synergistic biofilm formation by Parvimonas micra and Fusobacterium nucleatum. Anaerobe. 2020;62:102100.","journal-title":"Anaerobe"},{"issue":"2","key":"775_CR113","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/omi.12429","volume":"39","author":"RP Settem","year":"2024","unstructured":"Settem RP, Ruscitto A, Chinthamani S, Honma K, Sharma A. Tannerella forsythia scavenges Fusobacterium nucleatum secreted NOD2 stimulatory molecules to dampen oral epithelial cell inflammatory response. Mol Oral Microbiol. 2024;39(2):40\u20136.","journal-title":"Mol Oral Microbiol"},{"issue":"7","key":"775_CR114","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1128\/IAI.06276-11","volume":"80","author":"RP Settem","year":"2012","unstructured":"Settem RP, El-Hassan AT, Honma K, Stafford GP, Sharma A. Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect Immun. 2012;80(7):2436\u201343.","journal-title":"Infect Immun"},{"issue":"37","key":"775_CR115","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2516574122","volume":"122","author":"F Shen","year":"2025","unstructured":"Shen F, Li L, Yang D, Tang Z, Zhang L, Liu K, et al. Binding of Fusobacterium nucleatum autotransporter adhesin CbpF to human CEACAM1 and CEACAM5: a velcro model for bacterium adhesion. Proc Natl Acad Sci U S A. 2025;122(37):e2516574122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"775_CR116","doi-asserted-by":"crossref","unstructured":"Galaski J, Shhadeh A, Uma\u00f1a A, Yoo CC, Arpinati L, Isaacson B, et al. Fusobacterium nucleatum cbpF mediates inhibition of T cell function through CEACAM1 activation. Front Cell Infect Microbiol. 2021;11:692544.","DOI":"10.3389\/fcimb.2021.692544"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00775-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00775-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00775-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:02:03Z","timestamp":1763604123000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00775-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00775-4","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}